瘤内注射治疗婴幼儿颌面部血管瘤  

Intratumoral injection for infant maxillofacial hemangioma

作　　者：董欣竞[1] 周德凯[1] 李晓庆[1] 

机构地区：[1]重庆医科大学附属儿童医院普外科,重庆400014

出　　处：《重庆医科大学学报》2006年第6期886-888,共3页Journal of Chongqing Medical University

摘　　要：目的:观察和总结瘤内注射治疗颌面部血管瘤的疗效。方法:采用醋酸曲安奈德注射液加平阳霉素局部注射治疗婴幼儿颌面部血管瘤,如一次注射治疗未愈的,间隔4～6周重复给药,4次为一个疗程,醋酸曲安奈德总量不超过100mg,平阳霉素总量不超过40mg;观察肿瘤消退情况。结果:84例患儿,经1年随访,治愈率(90.4%),显效率(7.1%),无效率(2.4%)。结论:本方法疗效可靠、副作用小、外观较满意,适合婴幼儿颌面部血管瘤的治疗。Objective：To observe and summarize the therapeutic effects of intratumoral injection with Triamcinolone Acetonide Acetate and Pingyangmycin on infant maxillofacial hemangloma.Methods：Local injection with Triamcinolone Acetonide Acetate （TAA）and Pingyangmycin （ PYM ）was executed to treat infant maxillofacial hemangioma. If the lesion did not disappear, the treatment would be performed again every four to six weeks at intervals, and the total dose of TAA and PYM could not be more than 100mg and 40mg respectively. The injection treatment was repeated 4 times for one course and the therapeutic effects of maxillofacial hemangioma were detected.Results： 84 cases with maxillofacial hemangioma, treated by local injection with TAA and PYM, had been followed up for one to three years.The cure rate was 90.4%, the notable rate was 7.1%, and the ineffective rate was 2.4%. Conclusions ： The intratumoral injection with Triamcinolone Acetonide Acetate and Pingyangmycin is the reliable therapy method with less side effects. It is valuable for treatment of infant maxillofacial hemangioma.

关 键 词：醋酸曲安奈德 平阳霉素 瘤内注射 血管瘤 

分 类 号：R739.81[医药卫生—肿瘤]